The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 04, 2011

Filed:

May. 26, 2006
Applicants:

Josef Messinger, Sehnde, DE;

Heinrich-hubert Thole, Hannover, DE;

Bettina Husen, Hannover, DE;

Michael Weske, Burgdorf, DE;

Pasi Koskimies, Turku, FI;

Lila Pirkkala, Kaarina, FI;

Inventors:

Josef Messinger, Sehnde, DE;

Heinrich-Hubert Thole, Hannover, DE;

Bettina Husen, Hannover, DE;

Michael Weske, Burgdorf, DE;

Pasi Koskimies, Turku, FI;

Lila Pirkkala, Kaarina, FI;

Assignee:

Abbott Products GmbH, Hannover, DE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/565 (2006.01); A61K 31/58 (2006.01); C07J 1/00 (2006.01); C07J 53/00 (2006.01); C07J 71/00 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention relates to novel substituted steroid derivatives which represent selective inhibitors of the 17β-hydroxysteroid dehydrogenase type I (17β-HSD1) and, in addition, which may represent inhibitors of the steroid sulphatase, as well as to their salts, to pharmaceutical preparations containing these compounds and to processes for the preparation of these compounds. Furthermore, the invention concerns the therapeutic use of said novel substituted steroid derivatives, particularly their use in the treatment, inhibition, prophylaxis or prevention of steroid hormone dependent diseases or disorders, such as steroid hormone dependent diseases or disorders requiring the inhibition of 17β-hydroxysteroid dehydrogenase type I and/or steroid sulphatase enzymes and/or requiring the lowering of the endogenous 17β-estradiol concentration.


Find Patent Forward Citations

Loading…